Key Metrics
CiteScore 

10.7
Impact Factor 

5 - 10
Scite Index 

0.89 5-Year SI

SNIP 

1.83
Recommended pre-submission checks
Powered by 

Clinical Pharmacology and Therapeutics Journal Specifications
Indexed in the following public directories
Web of Science
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1960 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Pharmacology and Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical Pharmacology and Therapeutics
Title not available
- 1 Jun 2026
- Clinical Pharmacology & Therapeutics
Balancing Reassurance and Vigilance: Real-World Evidence in Post-Marketing Drug Safety.
- 1 Jun 2026
- Clinical pharmacology and therapeutics
Correction to "Real-World Outcomes of Pembrolizumab Monotherapy in Metastatic Non-Small Cell Lung Cancer by Age and Sex: A National Population-Based Study in Australia".
- 1 Jun 2026
- Clinical pharmacology and therapeutics
Model-Informed Dosing Strategies for Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma.
- 15 May 2026
- Clinical pharmacology and therapeutics
Systems Pharmacology Approach to Paroxysmal Nocturnal Hemoglobinuria: Quantitative Framework for Biomarker Dynamics across Multi-Mechanistic Therapies.
- 15 May 2026
- Clinical pharmacology and therapeutics
Ten-Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits Scheme.
- 15 May 2026
- Clinical pharmacology and therapeutics
Title not available
- 1 Jun 2026
- Clinical Pharmacology & Therapeutics
Balancing Reassurance and Vigilance: Real-World Evidence in Post-Marketing Drug Safety.
- 1 Jun 2026
- Clinical pharmacology and therapeutics
Correction to "Real-World Outcomes of Pembrolizumab Monotherapy in Metastatic Non-Small Cell Lung Cancer by Age and Sex: A National Population-Based Study in Australia".
- 1 Jun 2026
- Clinical pharmacology and therapeutics
Model-Informed Dosing Strategies for Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma.
- 15 May 2026
- Clinical pharmacology and therapeutics
Systems Pharmacology Approach to Paroxysmal Nocturnal Hemoglobinuria: Quantitative Framework for Biomarker Dynamics across Multi-Mechanistic Therapies.
- 15 May 2026
- Clinical pharmacology and therapeutics
Ten-Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits Scheme.
- 15 May 2026
- Clinical pharmacology and therapeutics